Gender-affirming hormone therapy and vascular health: walking the line between caution and confidence
This pilot study suggests a more pronounced progression of atherosclerosis in TW undergoing GAHT, detectable particularly through CCTA. These findings support refined CV monitoring and highlight the need for larger, long-term studies to guide preventive strategies in transgender populations.
Authors
- Thierry Couffinhal (ORCID: https://orcid.org/0000-0002-9217-2533)
- MARIE-ANGE RENAULT
- Romane Lebourdon
- Amandine Galioot
- Sami Fawaz (ORCID: https://orcid.org/0000-0002-2817-4518)
- Marion Camoin (ORCID: https://orcid.org/0000-0002-1388-2482)
- Antoine Tabarin
- Pierre Mora
- V. Maury
- Michel Montaudon
- Virginie Grouthier
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Hôpital Cardiologique du Haut-Lévêque (FR)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2026-01-04
- DOI
- https://doi.org/10.1093/eurjpc/zwaf789
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00